Cargando…
Activated estrogen receptor-mitogen-activated protein kinases cross talk confer acquired resistance to lapatinib
BACKGROUND: The efficacy of lapatinib is limited by the development of acquired resistance. The aim of this study was to investigate the role of estrogen receptor (ER) signaling compensatory activation in acquired resistance to lapatinib in breast cancer cells BT474 and the related mechanism. METHOD...
Autores principales: | Li, Zhe, Yang, Sheng-Sheng, Yin, Pei-Hao, Chang, Tao, Shi, Lin-Xiang, Fang, Lin, Fang, Guo-En |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632920/ https://www.ncbi.nlm.nih.gov/pubmed/26557906 http://dx.doi.org/10.1111/1759-7714.12239 |
Ejemplares similares
-
Genome-wide identification and transcriptional expression analysis of mitogen-activated protein kinase and mitogen-activated protein kinase kinase genes in Capsicum annuum
por: Liu, Zhiqin, et al.
Publicado: (2015) -
Mitogen-Activated Protein Kinase Cross-Talk Interaction Modulates the Production of Melanins in Aspergillus fumigatus
por: Manfiolli, Adriana Oliveira, et al.
Publicado: (2019) -
Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
por: Ye, Min, et al.
Publicado: (2021) -
Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
por: Bao, Shengnan, et al.
Publicado: (2020) -
Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes
por: Dai, ChunLing, et al.
Publicado: (2015)